Curie Oncology
Singapore, Singapore
3 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 3
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Breast Neoplasms
BioNTech SE558 enrolled155 locationsNCT07173751
Recruiting
Phase 1Phase 2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Gastric CancerUrothelial CarcinomaMelanoma+5 more
Inhibrx Biosciences, Inc340 enrolled42 locationsNCT04198766
Recruiting
Phase 3
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Metastatic Non Small Cell Lung Cancer
NovoCure GmbH734 enrolled98 locationsNCT06216301
Recruiting
Phase 3
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Metastatic Breast Cancer
LeonaBio600 enrolled224 locationsNCT05696626
Recruiting
Phase 1
A Study of ZW191 in Participants With Solid Tumors
Advanced Solid Tumors
Zymeworks BC Inc.145 enrolled27 locationsNCT06555744
Recruiting
Phase 2
A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma
Hepatocellular Carcinoma
Coherus Oncology, Inc.72 enrolled44 locationsNCT06679985